GeneGo to Sell Omicsoft Products
ST. JOSEPH, Mich., Jan. 5 /PRNewswire/ — GeneGo, Inc., the leading systems biology tools company, announced today that they will be selling Omicsoft products Array Studio and Array Server globally except for Japan. Array Studio is a software package which provides state of the art statistics and visualization for the analysis of high dimensional quantification data (OMICs data). Array Server is an enterprise data repository solution, allowing users to store, share, search, and integrate their microarray/SNP/CNV projects and data. These tools are seamlessly integrated with GeneGo’s data mining suites MetaCore(TM) and MetaDrug(TM) allowing in depth analysis of different types of OMICs data.
“We are very delighted to set up this collaboration with GeneGo Inc. At Omicsoft, we focus on biomarker data management, visualization, and analysis. To achieve this, we design software that is easy enough to be used by the bench scientist, but powerful enough to be used by the bioinformatician or statistician. We have also fully analyzed more than 5,000 public datasets for our users. Interpretation of both public and proprietary datasets requires sophisticated bioinformatics tools such as those from GeneGo. GeneGo’s success in this area is unparalleled, and we hope to contribute to their continued success with this agreement. The collaboration was triggered by the same feature-on-demand philosophy shared by the two companies: improving our solutions based on customer requests. With this partnership, Omicsoft can continue to focus on new technology developments, including next generation sequencing enterprise solutions,” said Jack Liu, President of Omicsoft. “Interpretation of complex OMICs datasets requires both empirical statistical analysis of large data repositories and ‘knowledge-based’ functional analysis based on manually curated pathways and ontologies. We believe that Omicsoft’s and our products are ‘best in class’ in the corresponding fields, so bundling our solutions makes perfect scientific and commercial sense,” said Julie Bryant, GeneGo’s VP of Business development. “Many of our customers see the value in easy access, search and retrieval of public domain experimental data, followed by functional ‘pathway’ analysis, including ontology enrichment, networks and interactome topology. While working with Omicsoft, we were impressed with their tools and now we look forward to representing them in the field.”
About GeneGo, Inc.
GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo’s flagship product, MetaCore 6.0(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 6.0(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.
For more information, please visit the company’s web site at www.genego.com.
SOURCE GeneGo, Inc.